Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CINATRA: Epothilone B (patupilone) in metastatic colorectal cancer with microsatellite or chromosomal instability
2006-006073-24Phase 2Terminated
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Mar 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of patupilone in colorectal cancer (CRC), colon cancer and rectal cancer, sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: 12-week progression-free survival in unselected patients. Started Mar 2008; status: terminated.
02
Drugs
patupilone
03
Conditions
colorectal cancer (CRC)colon cancerrectal cancer
Beyond the preview
Go deeper on 2006-006073-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006073-24.